ArticleCureus2024
Serum C-peptide as a Predictor of Coronary Artery Disease in Middle-Aged Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Analytical Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Type 2 diabetes mellitus is a major public health problem. Coronary artery disease (CAD) is the major cause of morbidity and mortality due to diabetes. A subset of these patients develops this complication relatively early. Identifying such patients at increased risk of CAD using an appropriate marker is important in prevention. Insulin resistance plays an important role in the development and progression of atherosclerotic CAD. Measurement of serum C-peptide may help in identifying those with increased insulin resistance characterized by higher levels. This study was conducted to find the association between fasting C-peptide (FCP) levels and CAD in middle-aged patients with type 2 diabetes mellitus. Materials and methods This cross-sectional analytical study was done at the Medicine Outpatient Department of Government Medical College, Kannur, Kerala, South India. Type 2 diabetic patients aged 41-60 years were included. Patients on insulin, chronic liver disease, malignancy, critical illness, and an estimated glomerular filtration rate (eGFR) less than 45 ml/min/1.73 m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.